Spots Global Cancer Trial Database for prostatic neoplasm
Every month we try and update this database with for prostatic neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer | NCT04484701 | Prostatic Neopl... Prostatic Cance... | 68Ga-PSMA-11 | 19 Years - 99 Years | British Columbia Cancer Agency | |
| Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) | NCT04332744 | Metastatic Pros... | Enzalutamide Talazoparib | 18 Years - | MedSIR | |
| Trial of NanoPac Focal Therapy for Prostate Cancer | NCT04221828 | Prostate Cancer Prostate Adenoc... Prostate Cancer... Prostatic Neopl... Urogenital Neop... Genital Neoplas... Localized Cance... | NanoPac (steril... | 18 Years - | NanOlogy, LLC | |
| Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the Prostate | NCT03987737 | Prostatic Neopl... Prostate Cancer | small urinary c... | 45 Years - 80 Years | Universitaire Ziekenhuizen KU Leuven | |
| Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer | NCT01540994 | Prostatic Neopl... | radiation thera... | 50 Years - 90 Years | Sharp HealthCare | |
| High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation | NCT00126854 | Prostatic Neopl... | Magnetic Resona... | 18 Years - | AHS Cancer Control Alberta | |
| CT/MRI Co-registration Prostate Cancer | NCT00252460 | Prostatic Neopl... | Computed Tomogr... | 18 Years - | University Health Network, Toronto | |
| Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical Prostatectomy | NCT02526589 | Prostatic Neopl... Anastomosis | 18 Years - 90 Years | Tampere University Hospital | ||
| Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance. | NCT01310894 | Prostate Cancer | TOOKAD® Soluble | 18 Years - | Steba Biotech S.A. | |
| Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance. | NCT01310894 | Prostate Cancer | TOOKAD® Soluble | 18 Years - | Steba Biotech S.A. | |
| Exercise for Physical Health in Men With Prostate Cancer | NCT00660686 | Prostatic Neopl... Osteoporosis | Resistance Exer... Flexibility Tra... | 18 Years - 100 Years | OHSU Knight Cancer Institute | |
| Organoids From Metastases of Prostate Cancer | NCT03952793 | Prostatic Neopl... | extended biopsy | 18 Years - | Centre Antoine Lacassagne | |
| Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness | NCT05968144 | Prostatic Neopl... Survivorship Frailty Aging | Dietary recomme... Time-restricted... | 55 Years - | University of Maryland, Baltimore | |
| Impact of Exercise on Prognostic Biomarkers Related to Prostate Cancer | NCT03397030 | Prostatic Neopl... | Home-Based Exer... | 40 Years - | The University of Texas Health Science Center at San Antonio | |
| Bone Health Observational Study | NCT00632905 | Prostate Cancer | 18 Years - | CMX Research | ||
| Prostate Cancer Genetic Risk Evaluation and Screening Study | NCT05129605 | Prostatic Neopl... Prostate Cancer BRCA2 Mutation BRCA1 Mutation ATM Gene Mutati... MMR Mutation Lynch Syndrome Genetic Predisp... | Prostate cancer... | 35 Years - 74 Years | Massachusetts General Hospital | |
| A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC | NCT05849298 | Prostatic Neopl... | AAA617 AAA517 Piflufolastat F... ARPI ADT Best supportive... | 18 Years - | Novartis | |
| Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist. | NCT03361969 | Prostatic Neopl... | Estetrol Placebo Oral Ta... | 18 Years - | Pantarhei Oncology B.V. | |
| Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients | NCT01696539 | Prostatic Neopl... | Walking Interve... Standard of Car... | 40 Years - 80 Years | Örebro University, Sweden | |
| A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC | NCT05849298 | Prostatic Neopl... | AAA617 AAA517 Piflufolastat F... ARPI ADT Best supportive... | 18 Years - | Novartis | |
| A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer | NCT00001446 | Prostatic Neopl... | thalidomide | - | National Institutes of Health Clinical Center (CC) | |
| Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical Prostatectomy | NCT02526589 | Prostatic Neopl... Anastomosis | 18 Years - 90 Years | Tampere University Hospital | ||
| Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit | NCT03183544 | Prostatic Neopl... | Gallium-68 PSMA... | 18 Years - 70 Years | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer | NCT03104907 | Prostatic Neopl... Lower Urinary T... Urological Mani... Prostatic Disea... | Prostatic Arter... | - | Rigshospitalet, Denmark | |
| Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. | NCT06046131 | Prostatic Neopl... Adenocarcinoma Neoplasm Recurr... Neoplasm Metast... | Standard care | 18 Years - | Centre Hospitalier Universitaire de Pointe-a-Pitre | |
| Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer | NCT01540994 | Prostatic Neopl... | radiation thera... | 50 Years - 90 Years | Sharp HealthCare | |
| Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial | NCT00247312 | Prostatic Neopl... | Pd-103 | - | Schiffler Cancer Center | |
| Open Anterograde Radical Prostatectomy Compared to Open Retrograde Technique | NCT02687308 | Prostatic Cance... Prostatic Neopl... | 1 Retrograde ra... 2 Anterograde r... | 40 Years - 80 Years | Rio de Janeiro State University | |
| 68Ga PSMA in Preprostatectomy Patients | NCT03388346 | Prostate Cancer Prostatic Neopl... Prostatic Neopl... Prostatic Neopl... | Ga-68 PSMA-HBED... | 18 Years - | University of Iowa | |
| Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer | NCT04225299 | Localized Prost... | TOOKAD® | 18 Years - | Steba Biotech S.A. | |
| Detection Rate of Prostate Cancer in Men Undergoing MRI | NCT04398173 | Prostatic Neopl... | multiparametric... | 50 Years - | Fondazione del Piemonte per l'Oncologia | |
| EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression | NCT04266431 | Prostatic Neopl... | EMPOWER | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Study Using WST11 in Patients With Localized Prostate Cancer | NCT00975429 | Prostate Cancer | WST11 WST11 | 18 Years - | Steba Biotech S.A. | |
| A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer | NCT00401765 | Prostatic Neopl... | CNTO 328 Docetaxel | 18 Years - | Centocor, Inc. | |
| The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical Trial | NCT02966535 | Prostatic Neopl... Urinary Bladder... | Adjustment of M... Adjustment of M... | 20 Years - 90 Years | Seoul National University Hospital | |
| Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study | NCT02967458 | Prostatic Neopl... | Perflutren Lipi... | 18 Years - | Thomas Jefferson University | |
| Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP | NCT05667636 | Prostatic Neopl... | salvage SBRT | 18 Years - | Regina Elena Cancer Institute | |
| Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy | NCT03253744 | Prostate Cancer Prostatic Neopl... | 18F-DCFPyL Tumor Irradiati... Prostate + tumo... Tumor Irradiati... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy | NCT03253744 | Prostate Cancer Prostatic Neopl... | 18F-DCFPyL Tumor Irradiati... Prostate + tumo... Tumor Irradiati... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| MyProstateScore Equivalency With and Without DRE | NCT05700370 | Prostate Cancer | MyProstateScore | 45 Years - | LynxDx | |
| Preop Conformal Radiotherapy - Prostate | NCT00252447 | Prostatic Neopl... | Pre-Operative C... | 18 Years - | University Health Network, Toronto | |
| Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit | NCT03183544 | Prostatic Neopl... | Gallium-68 PSMA... | 18 Years - 70 Years | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy | NCT03242265 | Immunity, Innat... Prostatic Neopl... | IVDD for NK cel... | 18 Years - | ATGen Canada Inc | |
| Study of WST11 in Patients With Localized Prostate Cancer | NCT00707356 | Prostate Cancer | WST11 | 18 Years - | Steba Biotech S.A. | |
| A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma | NCT00001266 | Prostatic Neopl... | Suramin | - | National Institutes of Health Clinical Center (CC) | |
| SLPI for Prostate Cancer | NCT04854343 | Prostate Cancer Prostatic Neopl... | Secretory leuko... Determination o... Secretory leuko... | 18 Years - | University of Florence | |
| Exercise for Physical Health in Men With Prostate Cancer | NCT00660686 | Prostatic Neopl... Osteoporosis | Resistance Exer... Flexibility Tra... | 18 Years - 100 Years | OHSU Knight Cancer Institute | |
| A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer | NCT01337518 | Prostatic Neopl... | EZN-4176 | 18 Years - | Enzon Pharmaceuticals, Inc. | |
| Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy | NCT01936883 | Prostate Cancer | HDR LDR | 45 Years - 80 Years | British Columbia Cancer Agency | |
| Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients | NCT01696539 | Prostatic Neopl... | Walking Interve... Standard of Car... | 40 Years - 80 Years | Örebro University, Sweden | |
| Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy | NCT01316458 | Prostatic Neopl... Genital Neoplas... Neoplasms, Abdo... Urogenital Neop... Genital Disease... Prostatic Disea... Antineoplastic ... Imatinib | STI571 (Glivec®... | 18 Years - | Novartis | |
| Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate | NCT01996696 | Prostatic Neopl... | Metformin Placebo | 18 Years - | AHS Cancer Control Alberta | |
| Urinary and Prostate Microbiotes and Prostate Cancer | NCT03947515 | Prostatic Neopl... | prostate biopsy Urinary samplin... Rectal swabbing... | 18 Years - | Centre Hospitalier Universitaire de Nice | |
| Comparison of Multi-parametric and Bi-parametric Magnetic Resonance Imaging in Men With Suspicion of Prostate Cancer | NCT03693703 | Prostatic Neopl... | bi-parametric M... multi-parametri... | 18 Years - 75 Years | Fondazione del Piemonte per l'Oncologia | |
| Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer | NCT00769795 | Prostate Cancer | IMC-A12 Bicalutamide Goserelin | 18 Years - | University of Washington | |
| The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic Prostatectomy | NCT05566405 | Prostatic Neopl... | General Anaesth... Combined (Epidu... Open Retropubic... | - | Sismanoglio General Hospital | |
| 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer | NCT03389451 | Prostate Cancer Prostatic Neopl... Prostatic Neopl... Prostatic Cance... Prostatic Cance... | Ga-68 PSMA-HBED... | 18 Years - | University of Iowa | |
| Treatment Patterns in Metastatic Prostate Cancer | NCT02729103 | Prostatic Neopl... | Xofigo (Radium ... | 45 Years - | Bayer | |
| IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen | NCT01314118 | Prostate Cancer Prostatic Neopl... | abiraterone ace... | 18 Years - 99 Years | Janssen Biotech, Inc. | |
| Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic Surgery | NCT02977143 | Prostatic Neopl... Urinary Bladder... | Fluid loading o... | 20 Years - | Seoul National University Hospital | |
| Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer | NCT00426777 | Prostate Cancer | risedronate risedronate Control | 18 Years - | CMX Research | |
| A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms | NCT00001444 | Breast Cancer Lymphoma Neoplasm Prostatic Neopl... | 7-hydroxystauro... | - | National Institutes of Health Clinical Center (CC) | |
| Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer | NCT01875393 | Prostate Cancer | TOOKAD® Soluble | 18 Years - | Steba Biotech S.A. | |
| 68Ga PSMA in Preprostatectomy Patients | NCT03388346 | Prostate Cancer Prostatic Neopl... Prostatic Neopl... Prostatic Neopl... | Ga-68 PSMA-HBED... | 18 Years - | University of Iowa | |
| Organoids From Metastases of Prostate Cancer | NCT03952793 | Prostatic Neopl... | extended biopsy | 18 Years - | Centre Antoine Lacassagne | |
| SLPI for Prostate Cancer | NCT04854343 | Prostate Cancer Prostatic Neopl... | Secretory leuko... Determination o... Secretory leuko... | 18 Years - | University of Florence | |
| Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms | NCT00666926 | Head and Neck N... Prostatic Neopl... Pancreatic Neop... | PF00562271 PF00562271 PF00562271 PF00562271 | 18 Years - | Verastem, Inc. | |
| Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression | NCT06292897 | Prostate Cancer Prostate Adenoc... Prostate Neopla... Prostatic Neopl... Obesity | observational s... | 18 Years - | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | |
| Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression | NCT06292897 | Prostate Cancer Prostate Adenoc... Prostate Neopla... Prostatic Neopl... Obesity | observational s... | 18 Years - | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | |
| Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors | NCT03935282 | Breast Neoplasm Prostatic Neopl... Colorectal Neop... Endometrial Neo... Hodgkin Disease Non Hodgkin Lym... | AH-HA Tool in t... | 18 Years - | Wake Forest University Health Sciences | |
| Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP | NCT05667636 | Prostatic Neopl... | salvage SBRT | 18 Years - | Regina Elena Cancer Institute | |
| Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer | NCT00769795 | Prostate Cancer | IMC-A12 Bicalutamide Goserelin | 18 Years - | University of Washington | |
| Study Using WST11 in Patients With Localized Prostate Cancer | NCT00975429 | Prostate Cancer | WST11 WST11 | 18 Years - | Steba Biotech S.A. | |
| [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer | NCT04484701 | Prostatic Neopl... Prostatic Cance... | 68Ga-PSMA-11 | 19 Years - 99 Years | British Columbia Cancer Agency | |
| A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer | NCT00001446 | Prostatic Neopl... | thalidomide | - | National Institutes of Health Clinical Center (CC) | |
| Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial | NCT00243646 | Prostate Cancer | External beam r... Lupron Casodex | - | Schiffler Cancer Center | |
| Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer | NCT01431391 | Prostatic Neopl... Prostate Cancer Prostatic Adeno... | sipuleucel-T leuprolide acet... | 18 Years - | Dendreon | |
| Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) | NCT04332744 | Metastatic Pros... | Enzalutamide Talazoparib | 18 Years - | MedSIR | |
| Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy | NCT01316458 | Prostatic Neopl... Genital Neoplas... Neoplasms, Abdo... Urogenital Neop... Genital Disease... Prostatic Disea... Antineoplastic ... Imatinib | STI571 (Glivec®... | 18 Years - | Novartis | |
| Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness | NCT05968144 | Prostatic Neopl... Survivorship Frailty Aging | Dietary recomme... Time-restricted... | 55 Years - | University of Maryland, Baltimore |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
